| Incorporation of pazopanib in maintenance therapy of ovarian cancer A Du Bois, A Floquet, JW Kim, J Rau, JM Del Campo, M Friedlander, ... Journal of clinical oncology 32 (30), 3374-3382, 2014 | 380 | 2014 |
| Cactus pear: a natural product in cancer chemoprevention CZ D Zou, M Brewer, F Garcia, JM Feugang, J Wang, R Zang, H Liu Nutrition journal 4 (1), 25, 2005 | 315* | 2005 |
| Fifth ovarian cancer consensus conference of the gynecologic cancer intergroup: recurrent disease MK Wilson, E Pujade-Lauraine, D Aoki, MR Mirza, D Lorusso, AM Oza, ... Annals of Oncology 28 (4), 727-732, 2017 | 237 | 2017 |
| Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. A Du Bois, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, PT Jensen, ... Journal of Clinical Oncology 35 (15_suppl), 5501-5501, 2017 | 217 | 2017 |
| Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? RY Zang, ZT Li, J Tang, X Cheng, SM Cai, ZY Zhang, NN Teng Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 183 | 2004 |
| Randomized trial of cytoreductive surgery for relapsed ovarian cancer P Harter, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ... New England Journal of Medicine 385 (23), 2123-2131, 2021 | 176 | 2021 |
| Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20. A Du Bois, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ... Journal of Clinical Oncology 38 (15_suppl), 6000-6000, 2020 | 173 | 2020 |
| Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors R Jiang, J Tang, X Cheng, RY Zang European Journal of Surgical Oncology (EJSO) 35 (1), 92-97, 2009 | 159 | 2009 |
| Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort RY Zang, P Harter, DS Chi, J Sehouli, R Jiang, CG Tropé, A Ayhan, ... British journal of cancer 105 (7), 890-896, 2011 | 156 | 2011 |
| Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 … T Shi, J Zhu, Y Feng, D Tu, Y Zhang, P Zhang, H Jia, X Huang, Y Cai, ... The Lancet Oncology 22 (4), 439-449, 2021 | 143 | 2021 |
| A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection WJ Tian, DS Chi, J Sehouli, CG Tropé, R Jiang, A Ayhan, G Cormio, ... Annals of surgical oncology 19, 597-604, 2012 | 141 | 2012 |
| Current status of gynecological cancer in China K Kim, R Zang, SC Choi, SY Ryu, JW Kim Journal of gynecologic oncology 20 (2), 72-76, 2009 | 138 | 2009 |
| Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients J Li, Z Li, H Wang, R Zang, Y Zhou, X Ju, G Ke, X Wu Gynecologic oncology 121 (3), 565-570, 2011 | 117 | 2011 |
| Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women K Chen, H Ma, L Li, R Zang, C Wang, F Song, T Shi, D Yu, M Yang, W Xue, ... Nature communications 5 (1), 4682, 2014 | 113 | 2014 |
| Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer RY Zang, ZY Zhang, ZT Li, J Chen, MQ Tang, Q Liu, SM Cai Journal of surgical oncology 75 (1), 24-30, 2000 | 110 | 2000 |
| Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian … A Du Bois, A Floquet, JW Kim, J Rau, JM Del Campo, M Friedlander, ... Journal of clinical oncology 31 (18_suppl), LBA5503-LBA5503, 2013 | 100 | 2013 |
| Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation C Fotopoulou, R Zang, M Gultekin, D Cibula, A Ayhan, D Liu, R Richter, ... Annals of surgical oncology 20, 1348-1354, 2013 | 97 | 2013 |
| Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis Z Wang, Y Liu, L Lu, L Yang, S Yin, Y Wang, Z Qi, J Meng, R Zang, ... Oncotarget 6 (9), 6670, 2015 | 67 | 2015 |
| Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction WJ Tian, R Jiang, X Cheng, J Tang, Y Xing, RY Zang Journal of surgical oncology 101 (3), 244-250, 2010 | 66 | 2010 |
| Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer RY Zang, ZY Zhang, ZT Li, SM Cai, MQ Tang, J Chen, Q Liu European Journal of Surgical Oncology (EJSO) 26 (8), 798-804, 2000 | 65 | 2000 |
